Posted by West on February 6, 2010, at 14:58:30
In reply to Re: Oregon University's new antidepressant » conundrum, posted by linkadge on February 6, 2010, at 10:31:49
To all intents and purposes I have found concerta to be a completely different drug to mph ir. The L-isomer, L-threo-methyphenidate, is covered by several patents citing its use as a short-acting mood lifter to be used during the 2-6 week waiting period for antidepressants.
My experience so far (3-4 months) has shown concerta to add another level to my treatment, however I am diagnosed with ADD. Nevertheless I think it might have this benefit in those not diagnosed. Particularly, cognitive problems relating to treatment might - to a degree - be restored. You may feel you're getting your brain back and start to have some positive affect.
There are also positive implications regarding dopaminergic dysregulation if one is also taking an SSRI/SNRI (though I don't pretend to know a lot about this). I could see how MPH on its own could be problematic.
poster:West
thread:936057
URL: http://www.dr-bob.org/babble/20100204/msgs/936158.html